InfuCare Rx Founder-Led Buyback of One Equity Partners Stake

July 11, 2025

One Equity Partners has exited its investment in InfuCare Rx via a strategic, founder-led equity buyback. InfuCare Rx is a nationwide specialty infusion therapy provider treating complex and chronic conditions, operating three segments (IG Therapy, Specialty Infusion, Bleeding Disorders) and serving thousands of patients across all 50 states.

Buyers
Deven Patel / InfuCare Rx management (founder-led equity buyback)
Targets
InfuCare Rx
Sellers
One Equity Partners
Location
Connecticut, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.